How have IDNA shares performed in 2023?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $25.17 at the beginning of the year. Since then, IDNA shares have decreased by 16.1% and is now trading at $21.11. View the best growth stocks for 2023 here .

What does IDNA invest in?

iShares Genomics Immunology and Healthcare ETF is a equity fund issued by iShares. IDNA focuses on theme investments and follows the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund's investments total to approximately $120.94 million assets under management.

What stocks does iShares Genomics Immunology and Healthcare ETF hold?

IDNA invests in 58 holdings. Some of the stocks in their portfolio include Exelixis (EXEL) , Ginkgo Bioworks (DNA) , Regeneron Pharmaceuticals (REGN) , BioNTech (BNTX) , SpringWorks Therapeutics (SWTX) , Blueprint Medicines (BPMC) , BioCryst Pharmaceuticals (BCRX) , Twist Bioscience (TWST) , Iovance Biotherapeutics (IOVA) and Moderna (MRNA) .

What is the management fee for iShares Genomics Immunology and Healthcare ETF?

iShares Genomics Immunology and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IDNA is 0.47%.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE) , Gilead Sciences (GILD) , Intel (INTC) , AbbVie (ABBV) , Inovio Pharmaceuticals (INO) , Novavax (NVAX) , Canadian Natural Resources (CNQ) , QUALCOMM (QCOM) , SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY) .

Who are iShares Genomics Immunology and Healthcare ETF's major shareholders?

iShares Genomics Immunology and Healthcare ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Ameriprise Financial Inc. (1.63%), Integrated Wealth Concepts LLC (0.94%) and RiverFront Investment Group LLC (0.68%).

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

iShares Genomics Immunology and Healthcare ETF (IDNA) Price, Holdings, & News

$21.11

+0.11 (+0.52%)

(As of 12/7/2023 ET)

Compare

Today's Range: $20.91
▼
$21.18
50-Day Range: $17.37
▼
$21.29
52-Week Range: $17.33
▼
$28.06

Volume: 73,700 shs
Average Volume: 29,063 shs
Market Capitalization: $127.72 million

Assets Under Management: $120.94 million
Dividend Yield: 0.66%
Net Expense Ratio: 0.47%

Stock Analysis Chart Headlines Holdings Ownership Ratings

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.

IDNA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IDNA ETF News Headlines

November 15, 2023 | lse.co.uk

Ishares Eur Corp Bond Ex-financials 1-5yr Ucits Etf Eur (acc) Share Price (IX5A.AM)

November 13, 2023 | lse.co.uk

Ishares Uk Dividend Ucits Etf Dist Share Price (IUKD.MI)

December 8, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

November 3, 2023 | investing.com

IDNA ETF Stock Price History

May 30, 2023 | seekingalpha.com

IBDT iShares iBonds Dec 2028 Term Corporate ETF

May 24, 2023 | finance.yahoo.com

IDNA - iShares Genomics Immunology and Healthcare ETF

May 10, 2023 | investing.com

iShares MSCI Europe Health Care Sector UCITS ETF (ESIH)

May 9, 2023 | investing.com

iShares STOXX Europe 600 Health Care UCITS (SXDPEX)

December 8, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

April 26, 2023 | seekingalpha.com

IDNA iShares Genomics Immunology and Healthcare ETF

See More Headlines

Receive IDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: iShares
Fund Name: iShares Genomics Immunology and Healthcare ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:IDNA
Inception Date: 6/11/2019
Fund Manager: Jennifer Hsui, Greg Savage, Paul Whitehead
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Equity
Benchmark: NYSE FactSet Global Genomics and Immuno Biopharma Index
Category: Strategy
Focus: Theme
Development Level: Blended Development
Region: Global
Number of Holdings: 58

Fund Statistics

Assets Under Management: $120.94 million
Average Daily Volume: $0.00
Discount/Premium: -0.03%

Administrator, Advisor and Custodian

Administrator: State Street Bank and Trust Company
Advisor: BlackRock Fund Advisors
Custodian: State Street Bank and Trust Company
Distributor: BlackRock Investments, LLC
Transfer Agent: State Street Bank and Trust Company
Trustee: N/A
Lead Market Maker: Jane Street

Options

Optionable: N/A
Short Interest: 500 shs

Miscellaneous

Outstanding Shares: 6,050,000
Beta: 0.90
Creation Unit: 50,000
Creation Fee: $850.00

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

iShares Genomics Immunology and Healthcare ETF Expenses

Type	IDNA	Theme ETFs	Equity ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.47%	0.57%	0.53%	0.50%	0.51%
Other Expenses	0.00%	0.76%	0.54%	0.64%	0.57%
Total Expense	0.47%	0.73%	0.70%	0.73%	0.70%
Fee Waiver	0.00%	-0.78%	-0.54%	-0.69%	-0.57%
Net Expense	0.47%	0.60%	0.60%	0.57%	0.57%

iShares Genomics Immunology and Healthcare ETF (IDNA) Holdings & Exposure

Top 10 IDNA Holdings

Exelixis(NASDAQ:EXEL)
Holding Weight: 4.79%
Ginkgo Bioworks(NYSE:DNA)
Holding Weight: 4.69%
Regeneron Pharmaceuticals(NASDAQ:REGN)
Holding Weight: 4.66%
SANOFI SA
Holding Weight: 4.60%
BioNTech(NASDAQ:BNTX)
Holding Weight: 4.24%
GENMAB
Holding Weight: 4.22%
TAKEDA PHARMACEUTICAL LTD
Holding Weight: 4.19%
ROCHE HOLDING PAR AG
Holding Weight: 4.11%
BEIGENE LTD
Holding Weight: 3.86%
SpringWorks Therapeutics(NASDAQ:SWTX)
Holding Weight: 3.78%

IDNA Sector Exposure

IDNA Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

IDNA ETF - Frequently Asked Questions

How have IDNA shares performed in 2023?: iShares Genomics Immunology and Healthcare ETF's stock was trading at $25.17 at the beginning of the year. Since then, IDNA shares have decreased by 16.1% and is now trading at $21.11.
View the best growth stocks for 2023 here.
What does IDNA invest in?: iShares Genomics Immunology and Healthcare ETF is a equity fund issued by iShares. IDNA focuses on theme investments and follows the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund's investments total to approximately $120.94 million assets under management.
What stocks does iShares Genomics Immunology and Healthcare ETF hold?: IDNA invests in 58 holdings. Some of the stocks in their portfolio include Exelixis (EXEL), Ginkgo Bioworks (DNA), Regeneron Pharmaceuticals (REGN), BioNTech (BNTX), SpringWorks Therapeutics (SWTX), Blueprint Medicines (BPMC), BioCryst Pharmaceuticals (BCRX), Twist Bioscience (TWST), Iovance Biotherapeutics (IOVA) and Moderna (MRNA).
What is the management fee for iShares Genomics Immunology and Healthcare ETF?: iShares Genomics Immunology and Healthcare ETF's management fee is 0.47% and has no other recorded expenses or fee waivers. The net expense ratio for IDNA is 0.47%.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY).
Who are iShares Genomics Immunology and Healthcare ETF's major shareholders?: iShares Genomics Immunology and Healthcare ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Ameriprise Financial Inc. (1.63%), Integrated Wealth Concepts LLC (0.94%) and RiverFront Investment Group LLC (0.68%).
How do I buy shares of iShares Genomics Immunology and Healthcare ETF?: Shares of IDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSEARCA:IDNA) was last updated on 12/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial